Related Experiment Videos
Antimicrobial resistance in Staphylococcus aureus
1Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Abstract:
Recognized since 1883 as a common cause of infection, Staphylococcus aureus' preantimicrobial-era bacteremia mortality rate was 82%. The mortality of that era threatens to return as evidence of growing vancomycin resistance undermines the utility of vancomycin therapy. Successful treatment of S. aureus infections requires knowledge of its antimicrobial resistance capacity.
Insights
Staphylococcus aureus infections are a growing threat due to antimicrobial resistance. Understanding resistance is key to effectively treating these dangerous infections and preventing a return to high mortality rates.
Area of Science:
- Microbiology and Infectious Diseases
- Antimicrobial Resistance Research
- Clinical Medicine
Background:
- Staphylococcus aureus has been a recognized cause of infection since 1883.
- The pre-antimicrobial era saw an 82% mortality rate for S. aureus bacteremia.
- Emerging vancomycin resistance in S. aureus threatens to reverse treatment successes.
Purpose of the Study:
- To highlight the increasing threat of Staphylococcus aureus infections.
- To emphasize the critical need for understanding antimicrobial resistance in S. aureus.
- To underscore the importance of this knowledge for successful treatment outcomes.
Main Methods:
- Review of historical and current data on Staphylococcus aureus infections.
- Analysis of trends in antimicrobial resistance, particularly vancomycin resistance.
- Assessment of the impact of resistance on treatment efficacy and mortality rates.
Main Results:
- Growing vancomycin resistance is undermining a key treatment for S. aureus.
- The potential for a return to high mortality rates associated with S. aureus bacteremia.
- Antimicrobial resistance capacity is a critical factor in treatment success.
Conclusions:
- Effective treatment of Staphylococcus aureus infections is increasingly challenging.
- Knowledge of S. aureus antimicrobial resistance patterns is essential for clinical practice.
- Proactive strategies are needed to combat rising resistance and improve patient outcomes.